PMGC Holdings (ELAB) FCF Margin (2022 - 2026)
PMGC Holdings (ELAB) posted FCF Margin of 490.13% for Q1 2026, up 28.9% sequentially from 689.38% in Q4 2025, and up 39411.0% YoY from N/an in Q1 2025.
PMGC Holdings (ELAB) FCF Margin (2022 - 2026) Analysis & Trends
PMGC Holdings has reported FCF Margin for 5 years, with the latest figure at 490.13% in Q1 2026.
- Quarterly FCF Margin rose 39411.0% year-over-year to 490.13% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 650.57% (down 42563.0% YoY) and the FY2025 annual result came in at 1080.55%, down 85779.0% from the prior year.
- FCF Margin climbed to 490.13% in Q1 2026 per ELAB's latest filing, from 689.38% in the prior quarter.
- Over five years, FCF Margin peaked at 72.36% in Q3 2024 and troughed at 884.24% in Q1 2025.
- A 5-year average of 379.0% and a median of 341.85% in 2023 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2025 and 2026: FCF Margin tumbled 50459 bps in 2025, then jumped 39411 bps in 2026.
- Over 5 years, FCF Margin stood at 177.91% in 2022, then slumped by 92 bps to 341.85% in 2023, then increased by 19 bps to 277.96% in 2024, then tumbled by 148 bps to 689.38% in 2025, then rose by 29 bps to 490.13% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 490.13%, 689.38%, and 521.13% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | PMGC Holdings | 3.01 Mn | -15.78 Mn | 385,691.00 | -150.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -490.13% |
| Dec 31, 2025 | -689.38% |
| Sep 30, 2025 | -521.13% |
| Mar 31, 2025 | -884.24% |
| Dec 31, 2024 | -277.96% |
| Sep 30, 2024 | -72.36% |
| Jun 30, 2024 | -128.93% |
| Mar 31, 2024 | -379.66% |
| Dec 31, 2023 | -341.85% |
| Sep 30, 2023 | -92.74% |
| Jun 30, 2023 | -242.87% |
| Mar 31, 2023 | -627.85% |
| Dec 31, 2022 | -177.91% |